Direkt zum Inhalt
Merck

Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.

Chemosphere (2014-07-30)
Gracia Márquez, Eva M Rodríguez, Fernando J Beltrán, Pedro M Álvarez
ZUSAMMENFASSUNG

Aqueous solutions of mixtures of four pharmaceutical compounds (atenolol, hydrochlorothiazide, ofloxacin and trimethoprim) both in Milli-Q ultrapure water and in a secondary effluent from a municipal wastewater treatment plant have been treated at pH 7 by different oxidation methods, such as conventional ozonation, photolytic ozonation, TiO2 catalytic ozonation, TiO2 photocatalytic oxidation and TiO2 photocatalytic ozonation. Experiments were carried out using a solar compound parabolic concentrator. The performance results have been compared in terms of removal of emerging contaminants (ECs), generation rate of phenolic intermediates, organic matter mineralization, ecotoxicity removal and enhancement of biodegradability. Also, the consumption of ozone to achieve certain treatment goals (95% removal of ECs and 40% mineralization) is discussed. Results reveal that solar photocatalytic ozonation is a promising oxidation method as it led to the best results in terms of EC mineralization (∼85%), toxicity removal (∼90%) and efficient use of ozone (∼2mgO3mgEC(-1) to achieve complete EC removal and ∼18mgO3mgTOC(-1) to achieve 40% EC mineralization, respectively).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Titan(IV)-oxid, nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Anatase, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Titan(IV)-oxid, Anatase, powder, 99.8% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, ReagentPlus®, ≥99%
Sigma-Aldrich
Titan(IV)-oxid, Rutil, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Anatase, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Rutil, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Sigma-Aldrich
Titan(IV)-oxid, Mischung aus Rutil und Anatas, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Titan, foil, thickness 0.127 mm, 99.7% trace metals basis
Sigma-Aldrich
Titan, powder, <45 μm avg. part. size, 99.98% trace metals basis
Sigma-Aldrich
Titan, foil, thickness 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Mischung aus Rutil und Anatas, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
Titan, powder, −100 mesh, 99.7% trace metals basis
USP
Hydrochlorthiazid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Titan(IV)-oxid, Rutil, ≥99.98% trace metals basis
Supelco
Hydrochlorthiazid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Titan(IV)-oxid, Rutil, 99.995% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Titan, wire, diam. 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
Titan, sponge, 1-20 mm, 99.5% trace metals basis
USP
Trimethoprim, United States Pharmacopeia (USP) Reference Standard
Supelco
Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Titan(IV)-oxid, nanowires, diam. × L ~100 nm × 10 μm
Sigma-Aldrich
Titan, foil, thickness 2.0 mm, 99.7% trace metals basis
Titan, mesh, 100x100mm, nominal aperture 0.19mm, wire diameter 0.23mm, 60x60 wires/inch, open area 20%, twill weave